Volume 15 Supplement 1

Proceedings of the International Cancer Imaging Society (ICIS) 15th Annual Teaching Course

Open Access

Contrast enhancement for early cancer imaging by Gd-nanoparticles and active feedback MRI

Cancer Imaging201515(Suppl 1):P2

https://doi.org/10.1186/1470-7330-15-S1-P2

Published: 2 October 2015

Aim

Early detection of high-grade malignancy using enhanced MRI techniques significantly increases not only the treatment options available, but also the patients’ survival rate. For this purpose, we have developed a new method, termed “Active-Feedback MRI”. An active feedback electronic device was homebuilt to implement active-feedback pulse sequences to generate avalanching spin amplification, which enhances the weak field originated from T1 contrast agents such as Gd-nanoparticles that target and label the cancer cells.

Methods

The general principles of the “Active-Feedback MRI” can be found in our previous work (e.g., Science 290, 118, 2001). Here, its specific applications to image Gd-nanoparticles in early cancers were developed and demonstrated. (i) First, an active-feedback electronic device was home-built to generate feedback fields from the received FID current. The device is to filter, phase shift, and amplify the signal from the receiver coils and then retransmit the modified signal into the RF transmission coil, with adjustable and programmable feedback phases and gains. (ii) Next, an active-feedback pulse sequence was developed to enhance the contrast originated from local magnetic-field gradient variations due to Gd-nanoparticles.

Results

In vivo subcutaneous glioblastoma multiforme (GBM) and cervical cancer mice models were imaged. While T2 parameter images, T2-weighted images, and T1-Gd-weighted images could not clearly locate the early cancers, our active-feedback images and decay constant mapping successfully highlight the early cancers with a close correlation with histopathology. Statistical results show that this new approach provides significant improvements in cancer detection sensitivity, as measured by “contrast-to-noise ratio” (CNR) or “Visibility”.

Conclusion

In vivo subcutaneous xenografts GBM and cervical cancer mouse models validated the superior contrast/sensitivity and robustness of this approach towards early cancer detection. Spin dynamics and results from computer simulations will also be discussed.

Authors’ Affiliations

(1)
Department of Chemistry of Biochemistry, University Of California, Los Angeles

Copyright

© Ray et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement